Publications (39)

2023

  1. Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain

    PharmacoEconomics - Open

  2. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

2022

  1. Past and future of HIV infection. A document based on expert opinion

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 35, Núm. 2, pp. 131-156

  2. Patient Experience Evaluation of the CMO-Based Pharmaceutical Care Model vs Usual Care in People Living with HIV

    Journal of Multidisciplinary Healthcare, Vol. 15, pp. 2991-3003

  3. Contribución de cabotegravir + rilpivirina de acción prolongada al tratamiento de la infección por VIH-1

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 4, pp. 208-214

  4. Business intelligence for the visualization and data analysis of Telepharmacy activity indicators in a hospital pharmacy service scorecard

    Farmacia Hospitalaria, Vol. 46, pp. 24-30

  5. Achieving the UNAIDS goals by 2030 in people living with HIV: A simulation model to support the prioritization of health care interventions

    Enfermedades Infecciosas y Microbiologia Clinica

2021

  1. Metodología de la comparación indirecta ajustada con emparejamiento en la evaluación de fármacos hematooncológicos

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 45, Núm. 2, pp. 55-60

  2. IMPACT OF ANTIHYPERTENSIVE TREATMENT IN COVID-19 PATIENTS IN A TERTIARY CARE HOSPITAL

    European Journal of Clinical Pharmacy, Vol. 23, Núm. 4, pp. 220-225

  3. How do hospital pharmacists approach substitution of nanomedicines? Insights from a qualitative pilot study and a quantitative market research analysis in five european countries

    Pharmaceutics, Vol. 13, Núm. 7

  4. Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 21, Núm. 5, pp. 967-973

2020

  1. Gestión integral de la nutrición artificial domiciliaria: humanización e innovación al servicio del paciente

    Anales de la Real Academia Nacional de Farmacia, Vol. 86, Núm. 4, pp. 257-268

  2. Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain

    Clinical Rheumatology, Vol. 39, Núm. 10, pp. 2919-2930

  3. Biosimilars of monoclonal antibodies in inflammatory diseases and cancer: Current situation, challenges, and opportunities

    Farmacia Hospitalaria, Vol. 44, Núm. 3, pp. 100-108

  4. A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study

    PharmacoEconomics - Open, Vol. 4, Núm. 4, pp. 615-624

2019

  1. Clinical pharmacy services: From cost-effectiveness analysis to a productivity indicators model

    European Journal of Hospital Pharmacy

  2. Interacciones entre antineoplásicos orales y alimentos

    Anales de la Real Academia Nacional de Farmacia, Vol. 85, Núm. 2, pp. 167-181

  3. Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain

    ClinicoEconomics and Outcomes Research, Vol. 11, pp. 465-475

  4. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

    Therapeutic Advances in Gastroenterology, Vol. 12

2018

  1. 10 temas candentes en farmacia oncohematológica

    Sociedad Española de Farmacia Hospitalaria